SCHEMBL20109219

SCHEMBL20109219

C=C(C(C)c1ccccc1)P1(=S)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
CYP2D6 P10635 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
GFER P55789 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ELOVL1 Q9BW60 2/20 0.33
KCNQ2 O43526 1/20 0.33
MC4R P32245 1/20 0.33
OPRM1 P35372 2/20 0.32
OPRD1 P41143 2/20 0.32
OPRK1 P41145 2/20 0.32
OPRL1 P41146 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
FAAH O00519 1/20 0.31
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109215 0.86 ATM (0.33) ATMCYP2D6ALDH1A1KDM4EGFER
SCHEMBL20109250 0.82 CYP2D6 (0.36) ATMCYP2D6ALDH1A1KDM4EGFER
SCHEMBL20109150 0.82 CYP2D6 (0.36) ATMCYP2D6ALDH1A1KDM4EGFER
SCHEMBL20109206 0.78 HSD17B10 (0.42) ALDH1A1GFERMEN1KMT2ALMNA
SCHEMBL20109207 0.77 CYP2C19 (0.32) ALDH1A1KDM4E
SCHEMBL20113432 0.75 MMP8 (0.47) ALDH1A1KDM4EOPRD1MEN1KMT2A
SCHEMBL20109225 0.72 ALDH1A1 (0.41) ATMALDH1A1L3MBTL1LMNAMAPT
SCHEMBL20109212 0.71 TRPA1 (0.32) ATMALDH1A1KDM4EGFERL3MBTL1
SCHEMBL20109243 0.70 SIGMAR1 (0.32) ATMCYP2D6ALDH1A1KDM4EGFER
SCHEMBL20109134 0.70 DHODH (0.33) ATMCYP2D6ALDH1A1KDM4EGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 ATM 3008/4885CYP2D6 3429/4885ALDH1A1 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.